icon3

Vaccines Market By Type (Monovalent Vaccines & Multivalent Vaccines) By Patient Type (Pediatrics, Adults, Others) By Disease Indication (Varicella, Polio, Herpes Zoster, Others) By Technology (Conjugate Vaccines, Inactivated, Others) Regional Analysis & Forecast – 2026

  • OI-89
  • |
  • Published date: May, 2019
  • |
  • Life Sciences & Healthcare
  • |
  • 120 Pages

The vaccine helps in stimulating the body’s immune system to produce antibodies that aid in protecting the body against infectious diseases. The vaccines administration builds immunity in the body against the disease without contacting the disease. Vaccines are biological products that are used to enhance the body's immune response to prevent diseases, including cholera, typhoid, hepatitis, and influenza. Vaccines consist of weakened/killed microbes, toxins, or surface proteins for inducing immunity against specific diseases. Vaccinations thus are playing a crucial role to maintain sustainable health of people across different countries, and they are employed in various regional disease-prevention strategies. The demand for vaccinations has increased over the last few years, owing to the increase in the incidence of both viral and bacterial infectious diseases.

Market Overview


The global market for vaccines is expected to grow from USD xx billion in 2018 to USD xx billion by 2026, at a CAGR of x% from 2018 to 2026. Market growth is due to the high prevalence of infectious diseases, growing support of R&D for the vaccine, investments into vaccine development, and a rising focus on immunization.


In addition, emerging vaccines like Zika vaccines, dengue vaccines, cancer vaccines, and others, producing technologically advanced vaccines, advancements made in vaccine delivery devices, and increasing immunization programs supplement the market growth. Immunization currently prevents estimation of 2 to 3 million deaths every year. Further, an additional 1.5 million deaths can be evaded through improved global vaccination coverage. Increase in uptake of new and underused vaccines will prominently intensify its global usage over the forecast period.

The global vaccines market is highly competitive in nature with a high level of fragmentation, due to the presence of a greater number of local and global players that are operating worldwide. In order to maintain lead position in the market, the key players are making notable investments in the research and development activities, which are projected to enhance the competitive environment of the market in the next few years. The rising number of mergers, acquisitions and also strategic collaborations are expected to offer lucrative opportunities in the next coming years for the market players. The rise in the prevalence of several diseases and the emergence of several new diseases are anticipated to encourage the leading players to develop new and effective drugs and vaccines in the market. This is expected to enhance the market growth of the global vaccines in the next few years. In addition, the rise in emphasis on the development of new products is expected to support the growth of the market in the next few years.

Key Developments



  • Mar 2019: FDA approved expansion of Merck's Gardasil 9 vaccine [HPV] for adults 27 to 45.

  • Mar 2019: GeoVax labs to collaborate with Leidos Inc to develop malaria vaccine candidates.


Segmentation


The global vaccines Market is segmented on the basis of technology, type, route of administration, disease indication, patient type, and region.


Based on technology: Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, and Recombinant Vaccines.

Based on the Type: Monovalent Vaccines, Multivalent Vaccines.


Based on Disease Indication: Pneumococcal Disease, Influenza, DTP, Hepatitis, Human Papilloma Virus (HPV), Rotavirus, Meningococcal Disease, MMR (measles, mumps, and rubella), Varicella, Polio, Herpes Zoster, Dengue, and Other Disease Indications

Based on Route of Administration: Intramuscular and Subcutaneous Administration, Oral Administration, and Other Routes of Administration


Based on Patient Type: Pediatrics, Adults, and Travelers.


Based on the Region: Latin America, Europe, North America, Asia Pacific, and the Middle East and Africa.


North America is expected to dominate the market, which is attributed to factors including an increase in investments by government organizations and companies for promoting immunization as well as developing new vaccines. Europe holds the second largest share of this market due to the factors like availability of funds and ventures capital investments to develop new vaccines and increase in government initiatives that are driving the market growth in this region. The vaccines market in Asia is expected to grow at the highest CAGR during the forecast period. Asia is considered as one of the fastest-growing markets for vaccines.

Key players in the market are Astellas Pharma Inc. (Japan), CSL Limited (Australia), GlaxoSmithKline plc (UK), Johnson & Johnson (US), Emergent BioSolutions, Inc. (US), MedImmune, LLC (US), Merck & Co., Inc. (US), Serum Institute of India Pvt. Ltd. (India), Pfizer, Inc. (US), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Biological E (India), Sanofi Pasteur (France), Panacea Biotec (India),and Daiichi Sankyo (Japan).

Report Description: The report covers in-depth analysis on Global Vaccines Market. The report assesses the market products pipeline by stage of development (early development, pre-clinical, clinical and in approval), by application (Non-inflammatory acne, Inflammatory acne and others). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.

The report includes in-depth company profiles of key players in Global Vaccines Market. The company profile includes key information on overview, financial highlights, product portfolio, business strategies, and key recent developments.

The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.


Scope:



  • Provides detailed analysis of the market structure along with forecast of the various segments and sub-segments of the Global Vaccines Market.

  • Provides a comparative analysis of key marketed products and pipeline market products.

  • Provides key information on players involved on the Global Vaccines Market.

  • Provides a complete overview of market segments and the regional outlook of Global Vaccines Market.

  • Provides in-depth coverage of key news related toGlobal Vaccines Market, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates

Our research works on a holistic 360° approach to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involve the following steps:




  • Data Collation (Primary & Secondary)




  • In-house Estimation (Based on proprietary databases and Models)




  • Market Triangulation




  • Forecasting




  • Market-related information is assembled from both primary and secondary sources. 








  • Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services. 








  • Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others. 







  • Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. 



REPORT YOU MIGHT BE INTERESTED

Choose Licence Type

$4,850.00
$5,950.00


(For Corporate Licence Only) Complementary
Credit card Logo
Inquiry Before Buying

Related Reports


Contact Us

Email Us at: sales@optimainsights.org | Reach Us at: +91 966 6620 365 | +1 424 2554 365 (US)